VIDEO: COVID-19 pandemic led to delays in diagnosis for patients with cholangiocarcinoma

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

The challenges patients with cholangiocarcinoma faced were likely similar to the ones other patients with cancer were facing. And many institutions at the height of the pandemic had curtailed outpatient visits and procedures. There were difficulties in patients having access to for instance, endoscopic procedures, radiographic tests, radiographic procedures, and in addition to that, some patients had concerns regarding travel to medical institutions due to fear of exposure to COVID. So, I think the combination of these factors likely led to delays in diagnosis for patients with cancer, and I think that is certainly true for patients with cholangiocarcinoma as well. So likely delayed diagnosis, and, which of course impacts treatment. There's a delay in starting of treatment.